AXL and infection: To determine whether ZIKV also exploits these receptors to enter Sertoli cells, blocking antibodies to the TIM receptors (TIM-1 and TIM-4) and TAM receptors (Axl, Tyro-3 and Mer) were added to cells prior to infection with ZIKV.